Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.12.

  • Aytu Biopharma's Equity Ratio fell 5602.47% to 0.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12, marking a year-over-year decrease of 5602.47%. This contributed to the annual value of 0.15 for FY2025, which is 3492.18% down from last year.
  • Aytu Biopharma's Equity Ratio amounted to 0.12 in Q4 2025, which was down 5602.47% from 0.19 recorded in Q3 2025.
  • Aytu Biopharma's Equity Ratio's 5-year high stood at 0.53 during Q1 2021, with a 5-year trough of 0.12 in Q4 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.28 (2023), whereas its average is 0.31.
  • Data for Aytu Biopharma's Equity Ratio shows a peak YoY increase of 1764.61% (in 2025) and a maximum YoY decrease of 5602.47% (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Aytu Biopharma's Equity Ratio stood at 0.47 in 2021, then crashed by 31.3% to 0.32 in 2022, then decreased by 22.73% to 0.25 in 2023, then rose by 5.75% to 0.26 in 2024, then plummeted by 56.02% to 0.12 in 2025.
  • Its Equity Ratio stands at 0.12 for Q4 2025, versus 0.19 for Q3 2025 and 0.15 for Q2 2025.